Myovista wavecg goes into clinical use at the naya imaging center in denmark

Southlake, texas, july 27, 2023 (globe newswire) -- heart test laboratories, inc.  d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-based medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announces that its myovista® wavecgtm has been selected for commercial use in clinical practice by the naya imaging center in hvidore, denmark.
HSCS Ratings Summary
HSCS Quant Ranking